现金及等价物 更改
Agenus USD 35M 32M 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Celldex Therapeutics USD 35.73M 6.86M 2026-03
Eisai JPY 301.65B 16.27B 2025-09
Merck USD 5.33B 9.24B 2026-03
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Pfizer USD 1.7B 561M 2026-03
Plus Therapeutics USD 3.02M 1.23M 2026-03
Roche Holding CHF 7.55B 579M 2025-06